Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Personalis, Inc. United States | 1 | 269 |
|
Genetic Services Laboratory University of Chicago United States | 7 | 15 |
|
Genomic Diagnostic Laboratory, Division of Genomic Diagnostics Children's Hospital of Philadelphia United States | 4 | 1 |
|
OnkoRisk Hereditary Oncology Plus Panel BioReference Health United States | 97 | 77 |
|
Hereditary Cancer Screening - Nervous System & Endocrine Cancer Panel (44 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States | 52 | 44 |
|
Genesys Diagnostics Genesys Diagnostics, Inc. United States | 40 | 39 |
|
Hereditary Cancer Screening - Full Hereditary Cancer Panel (99 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States | 109 | 99 |
|
SMARCB1 Gene Mental retardation, autosomal dominant type 15 NGS Genetic DNA Test DNA Labs India India | 1 | 1 |
|
Mayo Clinic Laboratories Mayo Clinic United States | 1 | 19 |
|
Hereditary Expanded Cancer Panel Mayo Clinic Laboratories Mayo Clinic United States | 1 | 86 |
|
Tempus Labs, Inc. United States | 2 | 647 |
|
Schwannomatosis Panel on Tumor Block Medical Genomics Laboratory Department of Genetics UAB United States | 2 | 3 |
|
Rhabdoid Tumor Predisposition Syndrome NGS Panel Medical Genomics Laboratory Department of Genetics UAB United States | 5 | 2 |
|
Foundation Medicine, Inc. United States | 2 | 405 |
|
FAMILIAL SCHWANNOMATOSI - SMARCB1/INI1 gene Clinical Genomics Unit Hospital Universitari Germans Trias i Pujol Spain | 2 | 3 |
|
NEUROFIBROMATOSI DE TYPE 2 - NF2 gene Clinical Genomics Unit Hospital Universitari Germans Trias i Pujol Spain | 3 | 3 |
|
OncoAlly™ Comprehensive Hereditary Cancer Analysis Variantyx, Inc. United States | 1 | 88 |
|
Comprehensive HemeComplete Profile + Heme Fusion + CALR PCR + FLT3 PCR PathGroup United States | 16 | 160 |
|
Centogene AG - the Rare Disease Company Germany | 156 | 107 |
|
Centogene AG - the Rare Disease Company Germany | 218 | 135 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.